INTERVENTIONAL NEUROLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

The Global Interventional Neurology Market is estimated to be valued at USD 2.87 Bn in 2025 and is expected to reach USD 4.32 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032. Global Interventional Neurology Market is witnessing steady growth over the years and is expected to grow significantly during 2025-2032. Growing geriatric population and rising prevalence of neurological disorders, such as strokes and cerebrovascular diseases, are some of the major factors augmenting the growth of this market. In October 2022, according to the WHO estimate, around 17 million people suffer strokes annually across the globe. Neurological interventional devices offer minimally invasive procedures for the treatment of various neurological conditions with less complications and quicker recovery time compared to open surgeries. Advancements in interventional neurology technologies including liquid embolic agents, flow diversion stents, and coiling assist devices are further expanding the applications of interventional neurology procedures.

Market Dynamics:

The global interventional neurology market is driven by rising geriatric population, increasing prevalence of neurological disorders, and growing adoption of minimally invasive surgeries. However, high cost of interventional neurology devices, dearth of neurointerventional, and reimbursement issues in developing nations are some of the key factors restricting the market growth. Meanwhile, emerging economies represent huge opportunities for market players as they offer sizable patient pool and growing healthcare investments in these countries. Also, ongoing research and new product launches to expand applications of interventional neurology would create new avenues in the coming years.

Key Features of the Study:

- This report provides in-depth analysis of the global interventional neurology market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global interventional neurology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic, Terumo Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems, Stryker Corporation, W.L. Gore & Associates, B. Braun Melsungen AG, Abbott Laboratories, MicroPort Scientific Corporation, Medikit Co. Ltd., Asahi Intecc Co. Ltd., Cook Medical, and AngioDynamics

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- The global interventional neurology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional neurology market

Market Segmentation

• By Product Type Insights (Revenue, USD Bn, 2020 - 2032)
• • Embolic Protection Devices
  • Stents
  • Embolic Coils
  • Flow Diverter Devices
  • Stent Retrievers
  • Revascularization Device
  • Guide Sheaths
  • Neck Reconstruction Device
  • Catheters
  • Others
• By Application Insights (Revenue, USD Bn, 2020 - 2032)
• • Cerebral Aneurysm
  • Subarachnoid Hemorrhage (SAH)
  • Ischemic Strokes
  • Extracranial & Intracranial Atherosclerosis
  • Head and Neck Tumors
  • Others
• By Technique Insights (Revenue, USD Bn, 2020 - 2032)
• • Angioplasty
  • Coil Embolization
  • Embolectomy
  • Stenting
  • Thrombectomy
  • Others
• By End User Insights (Revenue, USD Bn, 2020 - 2032)
• • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
• • Boston Scientific Corporation
  • Medtronic
  • Terumo Corporation
  • Penumbra Inc.
  • Johnson & Johnson
  • Merit Medical Systems
  • Stryker Corporation
  • W. L. Gore & Associates
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • MicroPort Scientific Corporation
  • Medikit Co. Ltd.
  • Asahi Intecc Co. Ltd.
  • Cook Medical
  • AngioDynamics